No photo available

Professor Jim Lagopoulos

Fellow

  • Club/association Details
  •  
  • Role(s): Fellow
    Level: n/a
    Status: Active
  • Bio/Profile
  •  
  • Jim Lagopoulos is the director of USC's Thompson Institute (TI). He has been involved with neuroimaging for more than 20 years in both the public and private sectors, and over this time he has attained significant expertise in magnetic resonance imaging (MRI) and has established and run programs across three research centres. Jim's research is focused on the translation of discoveries made using animal models into real-world treatment options for humans. In the past six years, he has established an independent neuroimaging research program with a focus on traumatic brain injury and post traumatic stress disorder (PTSD).  Jim's research programs are focused on youth mental health, healthy brain ageing and dementia, PTSD, and traumatic brain injury. Jim has significantly contributed to collaborative and competitive grant funding totaling more than $30M, noting that he has also raised over $30m in donor, State, Federal and philanthropic foundation funding to establish the TI as a world leading translation medical institute in mental health. He has an international profile and is often invited to run neuroimaging workshops both nationally and internationally. He regularly accepts international speaking invitations on spectroscopic, structural and functional neuroimaging and has forged collaborations with esteemed international neuroimaging laboratories including Harvard and Yale Universities. Jim serves as Editor-in-Chief of Frontiers in Science as well as Editor of World Journal of Neuroscience, and he teaches into undergraduate and postgraduate programs at USC including professional development training for General Practitioners, Psychiatrists, and Allied Health professionals who work with young adults with emerging mental health conditions. Notably, many of his research articles appear in the highest-ranking international journals (e.g., Proceedings of the National Academy of Sciences, Alzheimer’s and Dementia and Progress in Neurobiology).